Malaria
In 1894, a Scottish physician named Ronald Ross visited Sir Patrick Manson at his home on Queen Anne Street in London. This meeting began four years of research that would change medicine forever. Ross worked at the Presidency General Hospital in Calcutta when he proved the complete life cycle of the malaria parasite inside mosquitoes. He isolated parasites from the salivary glands of mosquitoes that had fed on infected birds. Before this discovery, people believed the disease came from bad air or swamps. The term malaria itself comes from Medieval Italian words meaning bad air. Charles Louis Alphonse Laveran observed parasites inside red blood cells for the first time in 1880 while working in Algeria. He proposed that malaria was caused by this organism, marking the first time a protist was identified as causing human disease. The parasite enters the bloodstream through the bite of an infected female Anopheles mosquito. These mosquitoes prefer to feed at night, starting their search at dusk and continuing until they succeed. Inside the human body, sporozoites travel to the liver where they multiply into thousands of merozoites. After five to twenty-five days, these merozoites burst out and infect red blood cells. Each infected cell produces sixteen to thirty-two new parasites every two to three days. When the red blood cell bursts, it releases waste products that trigger fever and other symptoms. Only female mosquitoes transmit the disease because males feed only on plant nectar.
Symptoms typically begin ten to fifteen days after being bitten by an infected mosquito. Early signs include fever, chills, headache, nausea, vomiting, and diarrhea. Without treatment, the fever can settle into a regular pattern recurring every two or three days. Severe cases involve damage to vital organs like the kidney, liver, lungs, or brain. Cerebral malaria affects the brain and causes confusion, seizures, or coma. If untreated, cerebral malaria can lead to death within forty-eight hours of the first symptoms. Survivors may suffer long-term neurological damage including cognitive deficits and epilepsy. Severe anemia results from destruction of both infected and uninfected red blood cells. This is a major cause of deaths in children under five years old. Malaria during pregnancy increases risks of stillbirths, infant mortality, miscarriage, and low birth weight. Blackwater fever occurs when hemoglobin leaks into urine and often precedes kidney failure. Acute respiratory distress syndrome develops in up to twenty-five percent of severe cases. The parasite produces adhesive proteins called knobs on infected red blood cell surfaces. These knobs bind to blood vessel walls causing hypoxia and interfering with organ function. Infected cells sequester in capillaries throughout the body blocking normal blood flow.
Diagnosis typically begins by suspecting malaria based on symptoms and travel history. Clinicians should suspect malaria in anyone reporting fevers above 37.5 degrees Celsius without other obvious causes. Microscopic examination of Giemsa-stained blood remains the gold standard for confirmation. Microscopists examine thick films to scan many cells quickly and thin films to identify specific parasites. Under field conditions, microscopists can detect parasites when at least one hundred exist per microliter of blood. Rapid diagnostic tests offer an alternative where microscopy equipment is unavailable. These tests detect parasite proteins like lactate dehydrogenase or histidine rich protein two in fingerstick samples. HRP2 tests are widely used in Africa where P. falciparum predominates but cannot distinguish current from past infections. Polymerase chain reaction techniques amplify parasite DNA and identify species even at very low levels. PCR requires specialized laboratory equipment so it is rarely available in developing countries. It is generally used in developed nations to confirm diagnoses in returning travelers. The World Health Organization recommends testing children with anemia signs showing hemoglobin below eight grams per deciliter. Testing is only recommended for people with possible exposure to malaria in areas with little disease.
Malaria treatment guidelines since 2001 require two drugs in combination to prevent resistance. One drug must be a derivative of artemisinin while the other serves as a complementary agent. Artemether-lumefantrine taken orally over three days remains the most common first-line treatment for uncomplicated cases. Severe malaria usually requires intravenous artesunate until patients stabilize before switching to oral medication. Chloroquine was the predominant antimalarial medication until the nineteen-twenties when alternatives appeared. Resistance to chloroquine began developing in Southeast Asia during the nineteen-fifties and spread globally by the nineteen-eighties. Partial resistance to artemisinin emerged in Southeast Asia in 2001 and has since spread to parts of Africa. Proguanil resistance developed rapidly after its introduction in 1948, appearing just one year later. Drug combinations help overcome resistance but new medications remain urgently needed. Treatment duration varies between three and seven days depending on parasite species and location. Patients infected with P. vivax or P. ovale need additional seven to fourteen days of therapy to eliminate dormant liver stages. Even with proper treatment, severe malaria fatality rates range from thirteen to twenty percent. Survivors often face long-term health consequences including neurological damage and cognitive deficits.
Insecticide-treated nets offer greater than seventy percent protection compared to no net at all. Almost two point five billion ITNs have been distributed globally since 2004 according to UNICEF. By 2023, fifty-two percent of children in sub-Saharan Africa slept under these protective nets. Indoor residual spraying coats house walls with insecticides to kill resting mosquitoes after blood meals. Spraying must reach at least eighty percent of households in a community to be effective. Two malaria vaccines received World Health Organization endorsement by 2023. RTS,S known as Mosquirix completed clinical trials in 2014 and has protected up to three million children since pilot programs began in Ghana Kenya and Malawi. The second vaccine R21/Matrix-M showed seventy-seven percent efficacy in initial trials. These vaccines target children under five who are most vulnerable to severe infection. Malaria elimination requires reducing human population density mosquito population density and transmission rates simultaneously. If any factor drops sufficiently the parasite eventually disappears from that area. China eliminated malaria entirely in 2021 after announcing an elimination strategy in 2010. Similar programs in Tanzania would cost one-fifth of their public health budget making them economically challenging.
The World Health Organization reported 282 million new cases globally in 2024 across eighty endemic countries. Deaths attributed to malaria reached 610 thousand that same year according to their latest report. Children under five accounted for seventy-five percent of all malaria deaths in Africa during 2024. Sub-Saharan Africa continues bearing ninety-five percent of global cases and ninety-five percent of deaths. Nigeria Democratic Republic of Congo Uganda Ethiopia and Mozambique together responsible for more than half these infections. Countries with common malaria had average per capita GDP increasing only 0.4% annually between 1965 and 1990 compared to 2.4% elsewhere. The disease costs Africa US$12 billion every year through healthcare expenses lost work days and reduced tourism. Some countries experience thirty to fifty percent hospital admissions due to malaria alone. Public health spending reaches up to forty percent in heavily affected regions. Economic losses include decreased productivity from brain damage caused by cerebral malaria. Travelers to endemic areas lack immunity and face significant risks without proper prevention measures. Climate change expands transmission zones into higher altitudes previously too cold for mosquitoes.
Ancient Indian physician Sushruta believed the disease came from biting insects long before Roman Columella made similar observations. Hippocrates described periodic fevers labeling them tertian quartan subtertian and quotidian over two thousand years ago. Charles Louis Alphonse Laveran received the 1907 Nobel Prize for identifying parasites inside red blood cells. Ronald Ross won the 1902 Nobel Prize after proving mosquitoes transmit malaria to humans. He isolated parasites from mosquito salivary glands that had fed on infected birds. Chinese scientist Tu Youyou received the 2015 Nobel Prize for discovering artemisinin from Artemisia annua plants. Traditional Chinese herbal medicine sources influenced her work including texts written in 340 CE by Ge Hong. The first effective treatment came from cinchona tree bark containing quinine introduced to Europe around 1640. Quinine was extracted and named by French chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou in 1820. Malaria contributed to decline of the Roman Empire being known as Roman fever throughout history. European settlers likely brought malaria to Americas starting in sixteenth century alongside enslaved West Africans.
Up Next
Continue Browsing
Common questions
Who discovered the life cycle of malaria inside mosquitoes?
Ronald Ross proved the complete life cycle of the malaria parasite inside mosquitoes while working at the Presidency General Hospital in Calcutta. He isolated parasites from the salivary glands of mosquitoes that had fed on infected birds.
When did Charles Louis Alphonse Laveran observe parasites inside red blood cells for the first time?
Charles Louis Alphonse Laveran observed parasites inside red blood cells for the first time in 1880 while working in Algeria. This observation marked the first time a protist was identified as causing human disease.
How does the malaria parasite enter the human bloodstream and what happens next?
The parasite enters the bloodstream through the bite of an infected female Anopheles mosquito which prefers to feed at night starting at dusk. Inside the body sporozoites travel to the liver where they multiply into thousands of merozoites before bursting out to infect red blood cells.
What are the symptoms of cerebral malaria and how quickly can it lead to death if untreated?
Cerebral malaria affects the brain and causes confusion seizures or coma leading to death within forty-eight hours of the first symptoms if left untreated. Survivors may suffer long-term neurological damage including cognitive deficits and epilepsy.
Which countries were responsible for more than half of global malaria infections in 2024 according to the World Health Organization report?
Nigeria Democratic Republic of Congo Uganda Ethiopia and Mozambique together accounted for more than half of all malaria infections globally in 2024. Sub-Saharan Africa continued to bear ninety-five percent of global cases and deaths that year.